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In patients with chronic renal failure, on treatment with 
haemodialysis, clinical symptoms may development which are 
associated with abnormally high levels of aluminium in the 
blood and tissues. Such patients are exposed to aluminium via 
the dialysate fluid, from dietary sources, and from the ingestion 
of aluminium-containing antacids given to reduce phosphate 
absorption in the gut. 
Three syndromes are at present believed to be associated with 
aluminium toxicity in patients on haemodialysis. The first of 
these, termed 'dialysis encephalopathy' or 'dialysis dementia' is 
a progressive, fatal neurological disease first described in 
1971, 1 and since reported in many dialysis centres throughout 
the world. Patients dying with this condition show elevated 
levels of aluminium in many tissues, including brain grey 
matter. The brain levels of aluminium are significantly higher 
than those seen in dialysed patients dying from other causes. ' 
The second disorder is a progressive bone disease (dialysis 
osteodystrophy) distinct from other forms ofrenal bone disease 
and which has been shown to occur in regions where there are 
high concentrations of aluminium in the water supply used to 
prepare the dialysate. 3 Finally, there is evidence to suggest that 
aluminium toxicity is responsible for the development of a 
reversible microcytic anaemia in dialysis patients. 4 
The susceptibility of patients with chronic renal disease to 
aluminium toxicity has meant that a means to monitor alu­
minium in the body was required. Serum and plasma are now 
established as the most suitable body fluids for monitoring 
aluminium levels in these patients. 
The measurement of aluminium in dialysate solution allows 
the clinician to monitor a patient's level of exposure to this 
metal. This is particularly important in regions where the 
quality of water may vary, even from day to day. Although the 
use of reverse osmosis deionized water treatment to remove 
aluminium has been able to prevent exposure. contamination of 
the dialysate concentrate may still occur due to the manufactur­
ing process. 5 Concentrations of alumium of 1.0umolJL (27 ug/ 
L) or less in dialysate solution have been shown to reduce the 
incidence of fractures, 6 a result that was in agreement with an 
earlier epidemiological study. 7 
In this study, methods to determine aluminium concentration 
in plasma and dialysate solution were developed. 
EXPERIMENTAL 
Instrumentation 
A GBC 902 atomic absorption spectrophotometer and System 
2000 automated graphite furnace were used. The System 2000 
comprises the GF2000 graphite furnace, P AL2000 program­
mable automatic sample loader and CL2000 controller. A GBC 
Data Station with Omnicolour software was used to develop a 
furnace method, and to collect and store data. Real-time colour 
graphics of absorbance peaks allowed the operator to optimise 
furnace conditions. The isntrumental conditions for the deter­
mination of aluminium in plasma and dialysate solution are 
given in Fig. 1. The purge gas used was argon, as nitrogen 
produces a loss of sensitivity. 5 The flow rate was 4.2 Llmin. 
Reagents 
A stock solution of 1000 ug AlImL (aluminium nitrate, stand­
ard solution for atomic spectroscopy, BDH Chemicals. Aus­
tralia) was used to prepare standards in a plasma pool supplied 
by the Red Cross Blood Bank, Melbourne, Australia, and in 
dialysate solution pool. Dialysate concentrate, commercial 
name "Renalyte" (McCarthy Medical. England) was diluted 
(1.34) in reverse osmosis deionized water. This dialysate 
solution pool contained the following constituents: sodium, 
136 mmollL; calcium. 1.55 mmollL; potassium, 1.54 mmoll 
L; magnesium, 0.85 mmollL; chloride, 102.3 mmollL; ac­
etate, 40 mmollL; and dextrose, 2 glL. The manufacturer 
stated that this solution should contain less than 10 ug AIIL 
(0.37 umollL). AristaR nitric acid (BDH Chemicals, Aus­
tralia) was used. Ethylene diaminetetraacetic acid disodium 
salt (EDT A) and Triton X-lOO were also used (Univar. Ajax 
Chemicals, Australia). Deionized water for washing and rins­
ing was obtained from a mixed-bed deionizing unit (Service 
Exchange Deionization System, LiquiPure. Australia). 
Deionized water used for reagents and analysis was from a 
reverse osmosis, mixed-bed deionizing unit that supplies Type 
I ultrapure water (Modulab, Reagent Grade Model Water 
Systems, LiquiPure, Australia). 
Contamination Control 
All volumetric equipment including pipette tips and sample 
cups were soaked in2% mlV EDT A for a minimum of 8 hours, 
and rinsed in copious quanitties of deionized water. These 
items are then dried and used for sample and standard prepa­
ration. Sample cups were made of polyethylene. The matrix 
modifier for the method was 1% mlV Triton X-lOO which was 
stored in a cleaned plastic bottle. This solution contained less 
than 0.1 ulllol AIIL. Deionized water and reverse osmosis 
deionized water both contained less than 0.1 umol AIIL and 
were suitable for use in the method. Vessels that are open to the 
atmosphere during standard preparation should be covered to 
avoid contamination from aluminium in room dust. 5 
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Standard or Mean 
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Blank/Sample 0.00 0.000 
Std. I 1.84 0.148 
Std. 2 3.67 0.262 
Std. 3 5.48 0.362 
Concentration Units umo IlL 
GRAPHITE FURNACE PARAMETERS 
Final Ramp Hold 
Step Temp. Time Time Gas Read 
No. 'c. (sec) (sec) Type On 
80 5.0 5.0 Aux. No 
2 140 25.0 10.0 Aux . No 
3 1500 20.0 10.0 Aux. No 
4 1500 1.0 1.0 None No 
5 2700 1.0 4.0 None Yes 
Sampling Mode Auto Sampling 
Standards Preparation Pre-Mixed 
PRE-MIX SAMPLER VOLUMES 
Sample Volume (uL) 10 

Modifier Volume (uL) 10 

No. oflnjections 

Inject before Step No. 

Recalibration Rate 30 

Fig. I. Operating parameters for aluminium in dialysate solu­
tion 
Preparation of Calibration Standards 
Aluminium stock standard 1000 ug AlImL (37.06 umol All 
mL), was diluted to make up the intermediate standard by 
taking 10 mL and making up to a litre with deionized water. 
Volumes of 50, 100 and 150 uL of this intermediate standard 
were added to 10 mL aliquots of the plasma pool and the 
dialysate solution pool. The plasma standards and the dialysate 
standards each had concentrations of 1.84, 3.67 and 5.48 umol 
AlIL respectively (Fig. I). An aliquot of each pool was used as 
the blank for the partiuclar calibration curve and was placed in 
the blank position on the P AL2000. Either of the pool samples 
should contain less than 0.2 umol A IlL. The computer sub­
tracts the absorbance of the particular blank from all standards 
and then plots the standard curve. 
Preparation of Samples 
Patient samples should be collected using a standard 
venepuncture technique with particular reference to prevent­
ing aluminium contamination of the blood sample from the 
needle or the plastic syringe. A glass syringe or a glass sampler 
tube should not be used for blood collection. Collected whole 
blood should be dispensed into a pre-cleaned polythylene or 
polypropylene tube that has a suitable quantity of heparin to 
prevent coagulation. The added heparin should not elevate the 
aluminium concentration of the sample to a detectable level. 
After centrifugation, the plasma sample should be decanted 
into a second clean tube for storage. Refreigerate at 4°C if 
samples will be analysed in a few days. However for longer 
periods of storage samples should be frozen at -20°e. Plasma 
samples forthe analysis consisted ofSeronorm Trace Elements 
human reference serum batch no. 105 (Nycomed AS Diagnos­
tics, Oslo, Norway) and samples provided by the Department 
of Clinical Chemistry, Northern General Hospital, Sheffield, 
England. Plasma samples were measured directly using the 
autos ampler to dispense 10 uL into the graphite tube followed 
by 10 uL of Triton X-lOO matrix modifier. 
Dialysate solution samples should be collected into washed 
containers that have concentrated nitric acid added to give a 
final concentration of 1% VN to preserve the sample. Refrig­
erate the samples at 4°C if they will be analysed in a few days. 
However for longer periods of storage samples should be 
frozen at -20°C. Four dialysate samples, three of which had 
been spiked with known concentrations of aluminium, were 
obtained from the Department ofClinical Chemistry, Northern 
General Hospital , Sheffield, England. Dialysate solution sam­
ples were measured directly. The autosampler dispensed 10 uL 
into the graphite tube followed by 10 uL ofTriton X-lOO matrix 
modifier. 
Instrument Calibration and Operation 
The instrument was set to calibration mode and allowed to run. 
Once the calibration was complete the instrument was stopped 
to examine the calibration plot (Fig. 2) . At the instrument 
wavelength of 309.3 nm the calibration plot is curved since 
there are actually two lines at 309.27 and 309.28 nm with a 
predicted realtive absorption of 10: I respectively. 8 The 
addition of aluminium to a pool blank is a form of standard 
additions and the operator must be aware that due to this 
curvature errors will occur in the calibration if the endogenous 
aluminium concentration of the pool blank is not at the recom­
mended low concentration. 
If the calibration is suitable the analysis should be recom­
menced and the samples analysed without a calibration routine 
being performed. The Omnicolour software allows the analyst 
to quickly select "run application" and "sample selection" so 
that the run will start with the samples only. This procedure 
will prevent the absorbance of the blank being subtracted from 
the samples to gi ve falsely lower results. The rinse bottle for the 
PAL2000 was also soaked in 2% mN EDTA. The rinse 
solution contained 0.1 % VN nitric acid in 0.1 % VN Triton X­
100. This solution provided adequate cleaning of the tip and 
prevented sample carryover. 
RESULTS AND DISCUSSION 
The furnace program listed in Fig. I allowed complete drying 
of the plasma sample and modifier, and dialysate solution and 
modifier. The ashing temperature was chosen as I 500°C be­
cause high sensitivity was achieved at this temperature. The 
organic components of plasma were ashed at approximately 
700°C and the inorganic salts in plasma and dialysate solution 
were distilled off at approximately 1000°C The atomise tem­
perature was chosen as 2700°C, which is in agreement with 
most other methods. 
Table 1. Concentrations (umoUL) and percent recovery of 
aluminium added to dialysite solution 
Sample Al Added Result % Recovery 
Pool 0 0.17 
I 1.11 1.16 90.5 
2 2.22 2.35 98.1 
3 3.33 3.37 96.1 
Background correction mode was used in the plasma analysis, 
because biological samples have two possible sources of non­
specific absorption, namely organic and inorganic matrix com­
ponents. Although results for background-only mode showed 
negligible absorbance for the plasma standards or Seronorm, it 
is important to understand that considerable variation may 
occur in the composition of plasma samples from these pa­
tients. Also, for measurements at low concentration, reference 
range determination, or concentrations close to the detection 
limit, a falsely increased result may occur if background 
absorbance contributes significantly to the total absorbance. 5 
Seronorm has a recommended value of 2.6 umol A IlL. In this 
study the result obtained using peak height mode was 2.24 
umol A IlL compared to a value of 2.70 umol A IlL for peak 
area mode (Fig. 3). For both modes of data acquisition the 
precision obtained was very good. Consequently peak area was 
chosen as the measurement mode. The results for Seronorm 
indicate that the method is accurate in determining plasma 
aluminium. The method gave a characteristic mass of 14.8 pg 
Al for 10 uL plasma sample. 
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In clinics where reverse osmosis water purification systems are 
connected to haemodialysis machines the aluminium concen­
tration in dialysate should be less than lOug/L (0.37 umollL) 
9. Therefore, at low aluminium concentration a falsely in­
creased result may occur if the background absorbance of a 
dialysate solution contributes significantly to the total absorb­
ance. 5 Hence background correction was used for the analysis 
of dialysate solution. In the dialysate method the precision 
obtained was also very good. Peak area was chosen as the 
measurement mode. Percent recoveries for dialysate samples 
(Table 1) indicate that the method is accurate in determining 
dialysate solution aluminium concentration. The method gave 
a characteristic mass of 15.2 pg A I for a 10 uL dialysate 
solution sample. 
CONCLUSION 
These methods have been developed to allow simple and rapid 
analysis of aluminium in plasma and dialysate solution. If the 
analytical chemist takes due care to prevent contamination of 
reagents and samples both methods will be accurate and 
sensitive. The GBC 902 with System 2000 graphite furnace 
and data station allowed an automated analysis to be developed 
for methods that have been difficult to perform until recently. 
7. 	 Parkinson, I.S., Ward, M.K., Feest, T.G., et aI. , Lancet, 
1979, 1,406-409. 
8. 	 Gardiner, P.E., Stoeppler, M., and Nurnberg, H.W., 
Analyst, 1985, 110,611-617. 
9. 	 Savory, I., Berlin, A., Courtoux, C , et aI., Ann. Clin. 
Lab. Sci., 1983, 13, 444-451. 
The copyright of this article belongs to the Editorial Board of the Malta Medical Journal. The Malta 
Medical Journal’s rights in respect of this work are as defined by the Copyright Act (Chapter 415) of 
the Laws of Malta or as modified by any successive legislation. 
Users may access this full-text article and can make use of the information contained in accordance 
with the Copyright Act provided that the author must be properly acknowledged.  Further 
distribution or reproduction in any format is prohibited without the prior permission of the copyright 
holder. 
This article has been reproduced with the authorization of the editor of the Malta Medical Journal 
(Ref. No 000001) 
 
